Further to the investor presentation I found this transcript of TELA Bio Q3 conference call where an analyst from Canaccord Genuity asked about the Next Science deal and the medium term prospects of it. The CEO of TELA Bio response is below.
Very favourable outlook on the Xperience product!
https://www.nasdaq.com/articles/tela-bio-inc.-tela-q3-2021-earnings-call-transcript
Further to the investor presentation I found this transcript of...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.015(7.14%) |
Mkt cap ! $68.54M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 24.5¢ | 22.0¢ | $69.74K | 294.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7600 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 30225 | 2 |
View Market Depth
| Last trade - 15.18pm 25/06/2024 (20 minute delay) ? |
| NXS (ASX) Chart |